Publications in collaboration with researchers from Hospital Universitario La Paz (14)

2026

  1. CKD as an independent driver of polypharmacy

    Clinical Kidney Journal

2025

  1. Magnitude of chronic kidney disease in Spain

    Nefrologia

2024

  1. Including KDIGO cardiovascular risk stratification into SCORE scale could improve the accuracy to better stratify cardiovascular risk

    Nefrologia

  2. Preclinical gout is common in the patient with stages 3–5 chronic kidney disease: Relevance of musculoskeletal ultrasound

    Nefrologia

2023

  1. Including KDIGO cardiovascular risk stratification into SCORE scale could improve the accuracy to better stratify cardiovascular risk

    Nefrologia

2022

  1. Clinical characteristics, management, and one-year risk of complications among patients with heart failure with and without type 2 diabetes in Spain

    Revista Clinica Espanola, Vol. 222, Núm. 4, pp. 195-204

  2. Impact of different COVID-19 waves on kidney replacement therapy epidemiology and mortality: REMER 2020

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 11, pp. 2253-2263

  3. Risk of outcomes in a Spanish population with chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 7, pp. 1415-1424

  4. Risk of outcomes in a Spanish population with heart failure

    REC: CardioClinics, Vol. 57, Núm. 2, pp. 85-96

  5. The 2021 European Society of Cardiology Cardiovascular Disease Prevention Guidelines: Adding albuminuria to the SCORE scale increases the prevalence of very high/high cardiovascular risk among patients with chronic kidney disease

    Clinical Kidney Journal

2021

  1. Costs and healthcare utilisation of patients with chronic kidney disease in Spain

    BMC Health Services Research, Vol. 21, Núm. 1

  2. Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain

    Nefrologia, Vol. 41, Núm. 6, pp. 670-688

  3. The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy

    Kidney International, Vol. 99, Núm. 4, pp. 986-998

2020

  1. Costs and healthcare utilisation of patients with heart failure in Spain

    BMC Health Services Research, Vol. 20, Núm. 1